Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting

References

• Bryant PA, Katz NT. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review. Lancet Infect Dis. 2018;18(2):e45–e54. doi: 10.1016/S1473-3099(17)30345-6.
   PubMed Web of Science ®Google Scholar
• Durojaiye OC, Bell H, Andrews D, et al. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of sheffield (UK) OPAT service. Int J Antimicrob Agent. 2018;51(1):26–32. doi: 10.1016/j.ijantimicag.2017.03.016.
   PubMed Web of Science ®Google Scholar
• Mitchell ED, Czoski Murray C, Meads D, et al. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open. 2017;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
   PubMed Web of Science ®Google Scholar
• Douiyeb S, de la Court JR, Tuinte B, et al. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study. Int J Clin Pharm. 2022;44(2):557–563. doi: 10.1007/s11096-022-01379-7.
   PubMed Web of Science ®Google Scholar
• Durojaiye OC, Morgan R, Chelaghma N, et al. External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy. J Antimicrob Chemother. 2021;76(8):2204–2212. doi: 10.1093/jac/dkab127.
   PubMed Web of Science ®Google Scholar
• Chapman ALN, Patel S, Horner C, et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist. 2019;1:dlz026.
   PubMedGoogle Scholar
• Diamantis S, Dawudi Y, Cassard B, et al. Home intravenous antibiotherapy and the proper use of elastomeric pumps: systematic review of the literature and proposals for improved use. Infect Dis Now. 2021;51(1):39–49. doi: 10.1016/j.medmal.2020.10.019.
   PubMedGoogle Scholar
• Voumard R, Gardiol C, André P, et al. Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study. J Antimicrob Chemother. 2018;73(9):2540–2545. doi: 10.1093/jac/dky224.
   PubMed Web of Science ®Google Scholar
• Karimaghaei S, Rao A, Chijioke J, et al. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States. J Clin Pharm Ther. 2022;47(2):211–217. doi: 10.1111/jcpt.13550.
   PubMed Web of Science ®Google Scholar
• Allwood MC, Stonkute D, Wallace A, et al. Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (baxter) and accufuser (Woo Young Medical): a study compliant with the NHS yellow cover document (YCD) requirements. Eur J Hosp Pharm. 2020;27(2):90–94. doi: 10.1136/ejhpharm-2018-001515.
   PubMedGoogle Scholar
• Jamieson C, Ozolina L, Seaton RA, et al. Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS yellow cover document requirements. Eur J Hosp Pharm. 2022;29(4):212–216. doi: 10.1136/ejhpharm-2020-002340.
   PubMedGoogle Scholar
• Oliver G. Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy. Br J Nurs. 2016;25(19):S22–S27. doi: 10.12968/bjon.2016.25.19.S22.
   PubMedGoogle Scholar
• Zhang Y, Ody YC, Davis L. Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy. Br J Community Nurs. 2020;25(8):376–380. doi: 10.12968/bjcn.2020.25.8.376.
   PubMedGoogle Scholar
• Durojaiye OC, Jibril I, Kritsotakis EI. Palliative outpatient parenteral antimicrobial therapy (OPAT): a single center experience and systemic scoping review. A systematic review. Clin Infect Pract. 2022;16:100205. doi: 10.1016/j.clinpr.2022.100205.
   Google Scholar
• Durojaiye OC, Slucka A, Kritsotakis EI. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. Eur J Clin Microbiol Infect Dis. 2022;41(6):941–949. doi: 10.1007/s10096-022-04455-y.
   PubMed Web of Science ®Google Scholar
• British Society for Antimicrobial Chemotherapy (BSAC). The British society for antimicrobial chemotherapy outpatient parenteral antimicrobial therapy national outcomes registry system (NORS) user guide. BSAC, Birmingham, UK, 2018. https://e-opat.com/wp-content/uploads/2018/12/NORS-UserGuide-141218.pdf
   Google Scholar
• Ganapathy S, Amendola A, Lichfield R, et al. Elastomeric pumps for ambulatory patient controlled regional analgesia. Can J Anaesth. 2000;47(9):897–902. doi: 10.1007/BF03019672.
   PubMed Web of Science ®Google Scholar
• Schöffski P, Cerbone L, Wolter P, et al. Administration of 24-h intravenous infusions of trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: an effective and patient-friendly palliative treatment option. Onkologie. 2012;35(1-2):14–17. doi: 10.1159/000335879.
   PubMedGoogle Scholar
• Pandya KH, Eaton V, Kowalski S, et al. Safety of continuous antibiotic infusions administered through an Australian hospital in the home service: a pilot study. Pharm Pract Res. 2017;47(5):333–339. doi: 10.1002/jppr.1291.
   Google Scholar
• Ferreiro JLL, Otero JÁ, Rivo AS, et al. Outpatient therapy with piperacillin/tazobactam using elastomeric pumps in patients with Pseudomonas aeruginosa infection. Sci Rep. 2021;11(1):8610. doi: 10.1038/s41598-021-88179-7.
   PubMed Web of Science ®Google Scholar
• García-Queiruga M, Feal Cortizas B, Lamelo Alfonsín F, et al. Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting. Rev Esp Quimioter. 2021;34(3):200–206. doi: 10.37201/req/122.2020.
   PubMed Web of Science ®Google Scholar
• Manning L, Wright C, Ingram PR, et al. Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. PLoS One. 2014;9(7):e102023. doi: 10.1371/journal.pone.0102023.
   PubMed Web of Science ®Google Scholar
• Dubois-Silva Á, Otero-Plaza L, Dopico-Santamariña L, et al. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: a retrospective analysis of three years of clinical experience. Enferm Infecc Microbiol. Clin (Engl Ed). 2023; 41(6):321-328. doi: 10.1016/j.eimce.2021.11.012.
   PubMedGoogle Scholar
• Arensdorff L, Boillat-Blanco N, Decosterd L, et al. Adequate plasma drug concentrations suggest that amoxicillin can be administered by continuous infusion using elastomeric pumps. J Antimicrob Chemother. 2017;72(9):2613–2615. doi: 10.1093/jac/dkx178.
   PubMed Web of Science ®Google Scholar
• Barr DA, Semple L, Seaton RA. Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2012;31(10):2611–2619. doi: 10.1007/s10096-012-1604-z.
   PubMed Web of Science ®Google Scholar
• Bodycot J, Mashonganyika L, Kucziw N, et al. Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway. Br J Nurs. 2021;30(2):S4–S10. doi: 10.12968/bjon.2021.30.2.S4.
   PubMedGoogle Scholar
• Matthews PC, Conlon CP, Berendt AR, et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother. 2007;60(2):356–362. doi: 10.1093/jac/dkm210.
   PubMed Web of Science ®Google Scholar
• Durojaiye OC, Jibril I, Kritsotakis EI. Effectiveness of telemedicine in outpatient parenteral antimicrobial therapy (Tele-OPAT): a systematic review. J Telemed Telecare. 2022;0(0):1357633X221131842. doi: 10.1177/1357633X221131842.
   Google Scholar
• Saillen L, Arensdorff L, Moulin E, et al. Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps. Eur J Clin Microbiol Infect Dis. 2017;36(8):1387–1392. doi: 10.1007/s10096-017-2944-5.
   PubMed Web of Science ®Google Scholar
• Jenkins A, Shanu S, Jamieson C, et al. Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy services – the importance of storage and stability. Eur J Hosp Pharm. 2023;30(2):64–69. doi: 10.1136/ejhpharm-2021-002937.
   PubMedGoogle Scholar
• Jones TE, Selby PR, Mellor CS, et al. Ceftazidime stability and pyridine toxicity during continuous i.v. infusion. Am J Health Syst Pharm. 2019;76(4):200–205. doi: 10.1093/ajhp/zxy035.
   PubMed Web of Science ®Google Scholar
• Jenkins A, Hills T, Santillo M, et al. Extended stability of antimicrobial agents in administration devices. J Antimicrob Chemother. 2017;72(4):1217–1220. doi: 10.1093/jac/dkw556.
   PubMed Web of Science ®Google Scholar
• Jenkins A, Shanu S, Jamieson C, et al. Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS yellow cover document standards. Eur J Hosp Pharm. 2022;29(6):304–307. doi: 10.1136/ejhpharm-2021-002729.
   PubMedGoogle Scholar
• Sime FB, Wallis S, Jamieson C, et al. Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS yellow cover document. Eur J Hosp Pharm. 2023;30(e1):e76–e81. ejhpharm-2022-003286.
   PubMedGoogle Scholar
• Jamieson C, Allwood MC, Stonkute D, et al. Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS yellow cover document compliance for continuous infusions in an outpatient setting. Eur J Hosp Pharm. 2020;27(e1):e53–e57. doi: 10.1136/ejhpharm-2018-001699.
   PubMedGoogle Scholar
• Lui GY, Dickson HG, West D, et al. Elastomeric pump infusion failures caused by inadequate luer lock connector engagement to needleless connectors. J Infus Nurs. 2021;44(5):274–281. doi: 10.1097/NAN.0000000000000439.
   Web of Science ®Google Scholar
• Mizuuchi M, Yamakage M, Iwasaki S, et al. The infusion rate of most disposable, non-electric infusion pumps decreases under hypobaric conditions. Can J Anaesth. 2003;50(7):657–662. doi: 10.1007/BF03018707.
   PubMed Web of Science ®Google Scholar